Name | N-acetyl-D-mannosamine |
Synonyms | N-acetyl-D-mannosamine N-Acetyl-D-mannosamine N-Acetyl-D-mannosamine(ManNAc) N-ACETYL-D-MANNOSAMINE HYDRATE N-ACETYL-D-MANNOSAMINE MONOHYDRATE N-Acetyl-D-mannosamine monohydrate 2-(Acetylamino)-2-deoxy-β-D-mannopyranose 2-(acetylamino)-2-deoxy-beta-d-mannopyranos 2-ACETAMIDO-2-DEOXY-D-MANNOPYRANOSE HYDRATE 2-(acetylamino)-2-deoxyhexopyranose hydrate 2-(acetylamino)-2-deoxy-alpha-D-gulopyranose 2-ACETAMIDO-2-DEOXY-D-MANNOPYRANOSE HYDRATE, N-ACETYL-D-MANNOSAMINE HYDRATE |
CAS | 7772-94-3 |
InChI | InChI=1/C8H15NO6/c1-3(11)9-5-7(13)6(12)4(2-10)15-8(5)14/h4-8,10,12-14H,2H2,1H3,(H,9,11)/t4-,5-,6+,7+,8+/m1/s1 |
InChIKey | MBLBDJOUHNCFQT-YWIQKCBGSA-N |
Molecular Formula | C8H15NO6 |
Molar Mass | 221.21 |
Density | 1.50±0.1 g/cm3(Predicted) |
Melting Point | 130°C (dec.) |
Boling Point | 595.4±50.0 °C(Predicted) |
Flash Point | 313.9°C |
Solubility | Methanol (Slightly), Water (Slightly) |
Vapor Presure | 1.18E-16mmHg at 25°C |
Appearance | powder |
Color | White to Off-White |
BRN | 1346524 |
pKa | 12.04±0.70(Predicted) |
Storage Condition | Inert atmosphere,Store in freezer, under -20°C |
Stability | Hygroscopic |
Refractive Index | 1.575 |
MDL | MFCD00149493 |
Use | N-Acetyl-D-mannosamine (ManNAc) is used as a substrate to identify, differentiate and characterize enzymes such as N-acetyl-glucosamine epimerase(s) and aldolase(s). N-Acetyl-D-mannosamine is used for the synthesis of N-acetylneuraminic acid. |
Hazard Symbols | Xi - Irritant |
Risk Codes | 36/37/38 - Irritating to eyes, respiratory system and skin. |
Safety Description | S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. S36 - Wear suitable protective clothing. S24/25 - Avoid contact with skin and eyes. |
WGK Germany | 3 |
TSCA | Yes |
HS Code | 29329985 |
EPA chemical substance information | information provided by: ofmpeb.epa.gov (external link) |
biological activity | N-Acetyl-D-mannosamine (ManNAc, N-acetyl-beta-mannosamine) is a precursor of sialic acid, age-related synaptic transmission and attenuation of long-term potentiation (LTP) may be improved. N-Acetyl-D-mannosamine treatment is a potential therapeutic application for cognitive impairment. |